A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health
Clinical trial NCT03819049 · COMPLETED
Trial details
- NCT number
- NCT03819049
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-06
- Primary completion
- 2021-06-08
- Enrollment
- 836
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.